In Re Solaia Technology LLC Patent & Antitrust Litigation

346 F. Supp. 2d 1373, 2004 U.S. Dist. LEXIS 25040, 2004 WL 2853237
CourtUnited States Judicial Panel on Multidistrict Litigation
DecidedDecember 6, 2004
DocketMDL 1645
StatusPublished

This text of 346 F. Supp. 2d 1373 (In Re Solaia Technology LLC Patent & Antitrust Litigation) is published on Counsel Stack Legal Research, covering United States Judicial Panel on Multidistrict Litigation primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Solaia Technology LLC Patent & Antitrust Litigation, 346 F. Supp. 2d 1373, 2004 U.S. Dist. LEXIS 25040, 2004 WL 2853237 (jpml 2004).

Opinion

ORDER DENYING TRANSFER

WM. TERRELL HODGES, Chairman.

This litigation currently consists of the five actions listed on the attached Schedule A and pending in three districts as follows: two actions each in the Northern District of Illinois and the Eastern District of Wisconsin, and one action in the District of Minnesota. 1 The docket’s common party, Solaia Technology LLC, moves the Panel, pursuant to 28 U.S.C. § 1407, for an order centralizing this litigation in the Northern District of Illinois. All but one of the responding parties oppose transfer.

On the basis of the papers filed and hearing session held, the Panel finds that Section 1407 centralization would neither serve the convenience of the parties and witnesses nor further the just and efficient conduct of this litigation. Movant has failed to persuade us that any common questions of fact and law are sufficiently complex, unresolved and/or numerous to justify Section 1407 transfer in this docket in which some constituent actions have already been pending for over two years. We point out that alternatives to transfer exist that can minimize whatever possibilities there might be of duplicative discovery and/or inconsistent pretrial rulings. See, e.g., In re Eli Lilly and Company (Cephalexin Monohydrate) Patent Litigation, 446 F.Supp. 242, 244 (Jud.Pan.Mult.Lit.1978). See also Manual for Complex Litigation, Fourth, § 20.14 (2004).

IT IS THEREFORE ORDERED that the motion, pursuant to 28 U.S.C. § 1407, for centralization of the actions listed on Schedule A is denied.

*1374 SCHEDULE A

MDL-16J/.5 — In re Solaia Technology LLC Patent & Antitrust Litigation

Northern District of Illinois

Solaia Technology LLC v. ArvinMeritor, Inc., et al., C.A. No. 1:02-4704

Solaia Technology LLC v. Com Products International, Inc., et al., C.A. No. 1:03-9295

District of Minnesota

Ecolab, Inc., et al. v. Solaia Technology LLC, C.A. No. 0:03-3422

Eastern District of Wisconsin

Rockwell Automation, Inc., et al. v. Schneider Automation, Inc., et al., C.A. No. 2:02-1195

Solaia Technology LLC v. Rockwell Automation, Inc., et al., C.A. No. 2:03-939

1

. The Panel has also been notified of additional purportedly related actions pending in the Northern District of Illinois and the Eastern District of Wisconsin. In light of the Panel's disposition of this docket, the question of Section 1407 transfer with respect to these actions is moot.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Eli Lilly & Co.(cephalexin Monohydrate)
446 F. Supp. 242 (Judicial Panel on Multidistrict Litigation, 1978)

Cite This Page — Counsel Stack

Bluebook (online)
346 F. Supp. 2d 1373, 2004 U.S. Dist. LEXIS 25040, 2004 WL 2853237, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-solaia-technology-llc-patent-antitrust-litigation-jpml-2004.